Official UK visa sponsor profile for Esya Inc in London, including current register status, route details, and public company data.
Esya Inc., established in Chicago, Illinois, operates as an international company specializing in the development and commercialization of advanced diagnostic tools for Alzheimer’s disease detection. Founded in 2018, Esya leverages a proprietary technology – intracellular analytics utilizing DNA nanoprobes – to identify biomarkers indicative of early-stage cognitive decline before clinical symptoms become apparent. This innovative approach significantly improves patient prognosis through proactive intervention. The company's core business revolves around creating and validating diagnostic assays that analyze individual blood samples for specific genetic markers linked to Alzheimer’s progression. Esya’s patented technology offers a highly sensitive and accurate method compared to existing methods, minimizing the need for extensive clinical trials. We focus on providing solutions tailored to healthcare providers seeking early detection capabilities within their patient populations. Esya Inc. is classified as an international company under SIC Code: 6201 – Biotechnology, Pharmaceuticals & Medical Devices. The company’s operations are primarily supported by a Visa classification of Skilled Worker and a Worker rating (A). Our strategic focus centers on expanding our international presence through partnerships and collaborations to broaden access to this groundbreaking diagnostic tool globally.
Official UK visa sponsor profile for Esya Inc in London, including current register status, route details, and public company data.
Esya Inc., established in Chicago, Illinois, operates as an international company specializing in the development and commercialization of advanced diagnostic tools for Alzheimer’s disease detection. Founded in 2018, Esya leverages a proprietary technology – intracellular analytics utilizing DNA nanoprobes – to identify biomarkers indicative of early-stage cognitive decline before clinical symptoms become apparent. This innovative approach significantly improves patient prognosis through proactive intervention. The company's core business revolves around creating and validating diagnostic assays that analyze individual blood samples for specific genetic markers linked to Alzheimer’s progression. Esya’s patented technology offers a highly sensitive and accurate method compared to existing methods, minimizing the need for extensive clinical trials. We focus on providing solutions tailored to healthcare providers seeking early detection capabilities within their patient populations. Esya Inc. is classified as an international company under SIC Code: 6201 – Biotechnology, Pharmaceuticals & Medical Devices. The company’s operations are primarily supported by a Visa classification of Skilled Worker and a Worker rating (A). Our strategic focus centers on expanding our international presence through partnerships and collaborations to broaden access to this groundbreaking diagnostic tool globally.
Yes, Esya Inc is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Industry classification information is currently being updated for this sponsor.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Esya Inc is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Industry classification information is currently being updated for this sponsor.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.